Navigation Links
Anti-aging cosmetic reduced wrinkles in clinical trial
Date:4/28/2009

Scientists testing a cosmetic anti-ageing product sold on the high street have shown it can clinically reduce wrinkles and improve the appearance of skin damaged by everyday exposure to sunlight.

Dermatologists at The University of Manchester carried out a clinical trial on 60 volunteers with typical signs of sun-damaged skin and found that the cosmetic, No7 Protect & Perfect Intense Beauty Serum, could improve some of these clinical features.

The study, published online in the British Journal of Dermatology today (Tuesday, April 28), showed that 70% of individuals using the beauty product had significantly fewer wrinkles after 12 months of daily use compared to volunteers using a placebo.

The research team, headed by Professor of Dermatology Chris Griffiths, reported last year that the original No7 Protect & Perfect Beauty Serum stimulated the production of fibrillin-1, a protein that promotes elasticity in the skin.

For this latest, year-long study, the researchers first wanted to discover whether the new No7 Protect & Perfect Intense Beauty Serum also promoted fibrillin-1 production but also wished to test whether this would result in a reduction in wrinkles, as has been demonstrated with prescription retinoids.

"Very few over-the-counter cosmetic 'anti-ageing' products have been subjected to a rigorous, scientific trial to prove their effectiveness," said Professor Griffiths, who is based in the University's School of Translational Medicine at Salford Royal Foundation Hospital.

"Although prescription retinoids can have a reparative effect on photo-aged skin, there is scant evidence that any of the plethora of cosmetic 'anti-ageing' products can produce similar effects."

The clinical trial funded by Boots, the makers of the No7 product range was carried out using standard scientific protocols. Having established that the No7 Protect & Perfect Intense Beauty Serum did increase fibrillin-1
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Expose on Crimes Against Humanity as Perpetrated by the Gerontological Elite Asks Is Consensus in Anti-Aging Medical Intervention An Elusive Expectation or A Realistic Goal?
2. Perlabella Introduces a Highly Concentrated and Affordable Anti-Aging Skin Care Line
3. Glissandra Skincare Inc. Launches Website Showcasing New and Novel Anti-Aging Skincare Products
4. DNA Jewel to Finance Anti-Aging Services & Cancer Research
5. Anti-Aging Miracle Physicians Have Been Waiting for is Finally Here : Free Book Available From Natural Health News Report Reveals the Secret to Staying Young
6. Happy Birthday, StriVectin! The Skin Cream that Revolutionized the Anti-Aging Market
7. Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine
8. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
9. Anti-Aging Expo & Symposium Crowns a Personal Journey to Wellness
10. AMDLs Goodnak(R) Anti-Aging Skin Care Line Soon Available in Capsule & Lotion Form
11. Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGISTS GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... March 01, 2015 ERISAPros ... and Carolyn Roddy to the professional staff of its ... graduated from The Ohio State University-Mortiz College of Law. ... of experience working with several Fortune 500 companies as ... area of corporate benefits. Her experiences range from benefit ...
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims ... platform and gears towards the goal for a better ... group talks in smaller groups will be held after ... Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and ... youths. , Young adults aged between 18-30 ...
(Date:2/28/2015)... 28, 2015 Gerald “Solutionman” Haman surveyed ... or barriers to innovative thinking. “The #1 block ... lack of tools,” reports Haman, who created the Thinkubator ... of people felt that they did not have enough ... and resources to stimulate innovation. , Solutionman’s monthly “Accelerating ...
(Date:2/28/2015)... February 28, 2015 March—also known ... time to remind ourselves and others that suspected ... Atlantic NeuroSurgical Specialists (ANS). , Concussions are a ... for 75% of TBIs. There are 1.6-3.8 million ... sound benign, but it is a brain injury. ...
(Date:2/28/2015)... 28, 2015 A study out of ... gene therapy procedure for the treatment of a hereditary ... Authored by Dr. Robert MacLaren, professor of ... the Lancet Medical Journal on January 16, 2014 , ... rare genetic disorder that mostly affects men and leads ...
Breaking Medicine News(10 mins):Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2
... MALO CLINIC, a prestigious international healthcare and wellness center, will ... solution from Cypress Communications®. , ... ... prestigious international healthcare and wellness center, will implement the C4 ...
... M. Michael Wolfe, MD, chief of the Gastroenterology Section ... professor of physiology and biophysics at Boston University School ... Doctors by Castle Connolly Medical Ltd. , The America,s ... care, is a trusted and authoritative resource for identifying ...
... or panic disorder have a greater risk of subsequently ... the normal population, with higher rates occurring in younger ... journal, the European Heart Journal [1] today ... people who were younger than 50 when first diagnosed ...
... Agency should examine whether combined exposures to chemicals known ... says a new report from the National Research Council. ... assessment, should consider other chemicals that could potentially cause ... on chemicals that are similar in structure, which is ...
... men with chronic prostatitis, a painful disorder of the ... symptoms in recently diagnosed men who had not been ... trial sponsored by the National Institute of Diabetes and ... Institutes of Health (NIH). The study is to be ...
... that how we live our lives effects our health so ... lifestyle? Why do health professionals like doctors and counsellors ... health services, schools and education, the workplace, the internet, and ... living? For instance, can exercise help with addiction? How can ...
Cached Medicine News:Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 2Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 3Health News:MALO CLINIC Avoids Capital Expense and Gains Scalability with Hosted Unified Communications 4Health News:Boston University Medical Center gastroenterologist 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 3Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 2Health News:EPA should pursue cumulative risk assessment of phthalates and other chemicals 3Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:New Year starts with focus on healthy living 2Health News:New Year starts with focus on healthy living 3
(Date:2/27/2015)... , Feb. 27, 2015  In recognition of Rare ... to the global bleeding disorders community, CSL Behring ... international units (IUs) of protein therapies to the World ... profit organization which has worked to improve the lives ... The donation supports the WFH,s Global Alliance for Progress ...
(Date:2/27/2015)...  Uroplasty, Inc. (NASDAQ: UPI ), a medical ... products to treat voiding dysfunctions, today announced that it ... Tuesday, March 10, 2015. Rob Kill , President ... Officer, will present at 4:00 p.m. Pacific Time and ... at the Ritz Carlton in Laguna Niguel, ...
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... Use of ABILIFY In This Patient ... ... Otsuka,Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY ... supplemental New Drug Application for ABILIFY(R) (aripiprazole) for the,acute treatment of ...
... Feb. 28 DATATRAK International,Inc. (Nasdaq: DATA ), ... for the clinical trials industry, reported today that,it has ... six clinical,trial sponsors, as a result of its ongoing ... Inc. The value of these new,trials to DATATRAK is ...
Cached Medicine Technology:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 2U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 3U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 4U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 5U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 6U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 7U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 8U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 9DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 2DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 3DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 4DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects 5